SCHEMBL6014668

SCHEMBL6014668

CCO[PH](=O)CCNCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAOA P21397 1/20 0.46
CHRM2 P08172 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
DRD4 P21917 3/20 0.44
SIGMAR1 Q99720 3/20 0.42
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
ATM Q13315 1/20 0.41
SCN8A Q9UQD0 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15267586 0.83 SMN1; SMN2 (0.46) MEN1KMT2ATDP1MAOACHRM2
SCHEMBL8290989 0.78 TAAR1 (0.40) TDP1MAOAMAPTSMN1; SMN2ATM
SCHEMBL7192279 0.75 ADRA1A (0.42) MEN1KMT2ACHRM2SMN1; SMN2DRD3
SCHEMBL7429664 0.73 MAOB (0.44) MEN1KMT2AMAOACHRM2MAPT
SCHEMBL563886 0.73 TP53 (0.41) SMN1; SMN2
SCHEMBL13992719 0.71 CNR2 (0.40) KDM4EBCHE
SCHEMBL141336 0.70 MEN1 (0.73) MEN1KMT2ATDP1MAOACHRM2
SCHEMBL7574369 0.70 DRD4 (0.59) MEN1KMT2ATDP1MAOACHRM2
N-Benzylmethylamine SCHEMBL27514181 0.70 CYP3A4 (0.62) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL5764 0.70 MEN1 (1.00) MEN1KMT2ATDP1MAOACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
EP-1442027-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-04 EP disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed
WO-2003031419-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 MEN1 2372/4885KMT2A 1404/4885TDP1 554/4885
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 MEN1 2372/4885KMT2A 1404/4885TDP1 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.